BioSpace News Archive

BioMidwest

Royal Canin Launches Veterinary-exclusive Pill AssistTM Products

Pet Nutrition Company Introduces Canine Treat to Help Administer Medications

October 1, 2018
·
2 min read
Business

Zensights Names Dan Henry as Chief Innovation Officer

Zensights is pleased to announce that Dan Henry has joined the organization as Chief Innovation Officer.

October 1, 2018
·
2 min read
InteRNA Presents Expanded Preclinical Proof-of-concept Data on Lead Oncology Development Candidate INT-1B3 at the 14th Annual OTS Meeting

Two poster presentations highlight INT-1B3’s immune-system activation and CD8+ T cell-driven anti-tumor response in addition to its distinct MoA, targeting multiple hallmarks of cancer.

October 1, 2018
·
4 min read
Genetown

Corindus Technology Successfully used in Multiple Live Complex Robotic-Assisted Coronary Interventions at Transcatheter Cardiovascular Therapeutics 2018

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that its CorPath GRX System was used for multiple complex robotic-assisted percutaneous coronary interventions (PCI) at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2018 Conference.

October 1, 2018
·
5 min read
Drug Development

Viking Therapeutics Presents Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture in Plenary Oral Presentation at ASBMR 2018 Annual Meeting

Study Achieves Primary Endpoint, Demonstrating Statistically Significant, Dose-Dependent Increases in Lean Body Mass Ranging from 4.8% to 9.1% Following Treatment with VK5211

October 1, 2018
·
7 min read
BioMidwest

Data on Exicure’s TLR9 Agonist Spherical Nucleic Acid (SNA™) Construct Presented at the 4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Exicure technology shows effective antitumor activity in mouse tumor models

October 1, 2018
·
3 min read
Drug Development

AVEO Oncology Announces Initiation of Topline Analysis of Phase 3 TIVO-3 Trial

Analysis Initiated on the Unanimous Recommendation of the TIVO-3 Study Independent Steering Committee

October 1, 2018
·
9 min read
Lone Star Bio

Le-Vel Kicks Off Month-Long Campaign To Support Breast Cancer Research

Company Continues Commitment to Breast Cancer Awareness

October 1, 2018
·
3 min read
Business

The National Cancer Institute (NCI) Demonstrates Anti-Cancer Efficacy and Safety of Gibson’s Novel Class of Indenoisoquinolines in Advanced Canine Lymphoma

Gibson Oncology, LLC announced today that the National Cancer Institute (NCI) reported study results from an extensive multi-center canine study using Gibson’s Indenoisoquinolines (LMP400, LMP766, and LMP744) to treat 84 dogs with advanced stages of lymphoma.

October 1, 2018
·
2 min read
BioMidwest

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide.

October 1, 2018
·
2 min read